Abstract
Purpose
Computed tomography (CT) is current standard-of-care for preoperative staging in patients with invasive bladder cancer before radical cystectomy (RC). There are only sparse data on the association between preoperative CT findings and postoperative survival of patients.
Methods
We retrospectively evaluated preoperative CTs of 206 patients with invasive bladder cancer undergoing RC in an academic tertiary referral center. CTs were analyzed retrospectively for relative bladder wall thickness (BWT) and size of lymph nodes (LN). Associations between CT findings and risk of death from any cause (AC) as well as risk of death from bladder cancer (BC) were assessed by Kaplan–Meier estimates, cumulative incidence curves and multivariable Cox regression analysis.
Results
The median follow-up was 40 months. Increased BWT was significantly correlated with higher risk of death (AC: HR 1.68; p = 0.043; BC: HR 2.00; p = 0.027), as well as LN with a size of 6–10 mm (AC: HR 2.13; p = 0.002; BC: HR 2.77; p = 0.002) and >10 mm (AC: HR 2.47; p = 0.018; BC: HR 3.66; p = 0.007) when compared to LN ≤ 5 mm.
Conclusion
Our data showed a significant correlation of bladder wall thickness and LN size with the risk of death. Also lymph nodes >5 mm but ≤10 mm (resp. ≤8 mm)—usually considered non-pathologic—were associated with a significantly worse prognosis. This information can be used to counsel patients preoperatively. It might also be useful for a risk-adapted approach in regard to neoadjuvant chemotherapy.
Similar content being viewed by others
References
Global Burden of Disease Study 2010 (GBD) (2010) Results by cause 1990–2010 (2010) Institute for Health Metrics and Evaluation, University of Washington. http://ghdx.healthmetricsandevaluation.org/sites/ghdx/files/record-attached-files/IHME_GBD_2010_COD_1990_2010.CSV. Accessed 19 Jul 2013
Witjes JA, Comperat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A, European Associationof U (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65(4):778–792. doi:10.1016/j.eururo.2013.11.046
Hautmann RE, Gschwend JE, de Petriconi RC, Kron M, Volkmer BG (2006) Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176(2):486–492. doi:10.1016/j.juro.2006.03.038 (discussion 482–491)
Tjokrowidjaja A, Lee C, Stockler MR (2013) Does chemotherapy improve survival in muscle-invasive bladder cancer (MIBC)? A systematic review and meta-analysis (MA) of randomized controlled trials (RCT). J Clin Oncol 31:(suppl; abstr 4544)
Baltaci S, Resorlu B, Yagci C, Turkolmez K, Gogus C, Beduk Y (2008) Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int 81(4):399–402. doi:10.1159/000167836
Kim JK, Park SY, Ahn HJ, Kim CS, Cho KS (2004) Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. Radiology 231(3):725–731. doi:10.1148/radiol.2313021253
Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y (2010) Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 106(5):658–663. doi:10.1111/j.1464-410X.2010.09212.x
Maurer T, Souvatzoglou M, Kubler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U (2012) Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 61(5):1031–1038. doi:10.1016/j.eururo.2011.12.009
Picchio M, Treiber U, Beer AJ, Metz S, Bossner P, van Randenborgh H, Paul R, Weirich G, Souvatzoglou M, Hartung R, Schwaiger M, Piert M (2006) Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 47(6):938–944
Green DA, Durand M, Gumpeni N, Rink M, Cha EK, Karakiewicz PI, Scherr DS, Shariat SF (2012) Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. BJU Int 110(10):1463–1470. doi:10.1111/j.1464-410X.2012.11129.x
Papalia R, Simone G, Grasso R, Augelli R, Faiella E, Guaglianone S, Cazzato R, Del Vescovo R, Ferriero M, Zobel B, Gallucci M (2012) Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases. BJU Int 109(7):1031–1036. doi:10.1111/j.1464-410X.2011.10446.x
Maurer T, Horn T, Souvatzoglou M, Eiber M, Beer AJ, Heck MM, Haller B, Gschwend JE, Schwaiger M, Treiber U, Krause BJ (2014) Prognostic value of C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy. Urol Int 93(2):207–213. doi:10.1159/000357686
Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, Sylvester RJ, Kaasinen E, Bohle A, Palou Redorta J, Roupret M, European Associationof U (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639–653. doi:10.1016/j.eururo.2013.06.003
Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346
Team RC (2015) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
Dhar NB, Jones JS, Reuther AM, Dreicer R, Campbell SC, Sanii K, Klein EA (2008) Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder. BJU Int 101(8):969–972. doi:10.1111/j.1464-410X.2007.07335.x
Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247. doi:10.1016/j.ejca.2008.10.026
Barentsz JO, Engelbrecht MR, Witjes JA, de la Rosette JJ, van der Graaf M (1999) MR imaging of the male pelvis. Eur Radiol 9(9):1722–1736. doi:10.1007/s003300050916
Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A (2012) Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. Urology 79(6):1317–1321. doi:10.1016/j.urology.2012.01.040
Simone G, Bianchi M, Giannarelli D, Daneshmand S, Papalia R, Ferriero M, Guaglianone S, Sentinelli S, Colombo R, Montorsi F, Collura D, Muto G, Novara G, Hurle R, Rink M, Fisch M, Abol-Enein H, Miranda G, Desai M, Gill I, Gallucci M (2014) Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy. World J Urol. doi:10.1007/s00345-014-1465-4
Shariat SF, Karakiewicz PI, Godoy G, Lerner SP (2009) Use of nomograms for predictions of outcome in patients with advanced bladder cancer. Ther Adv Urol 1(1):13–26. doi:10.1177/1756287209103923
Booth CM, Siemens DR, Li G, Peng Y, Tannock IF, Kong W, Berman DM, Mackillop WJ (2014) Perioperative chemotherapy for muscle-invasive bladder cancer: a population-based outcomes study. Cancer. doi:10.1002/cncr.28510
Keegan KA, Zaid HB, Patel SG, Chang SS (2014) Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States. Curr Urol Rep 15(4):394. doi:10.1007/s11934-014-0394-5
Reardon ZD, Patel SG, Zaid HB, Stimson CJ, Resnick MJ, Keegan KA, Barocas DA, Chang SS, Cookson MS (2014) Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Eur Urol. doi:10.1016/j.eururo.2014.01.009
Author contributions
Project development: SCS, TZ, KH, JEG, MR, TM. Data collection: SCS, TZ, TH, IM, AKS. Data analysis: SCS, TZ, KH, BH, TH, TM. Manuscript writing: SCS, TZ, BH. Manuscript revision/editing: TH, KH, AKS, JEG, MR, TM. Statistical analysis: SCS, BH, IM.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical standard
The study was conducted according to local and national regulations and approved by the local ethics committee.
Additional information
Sebastian Christoph Schmid and Tina Zahel have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Schmid, S.C., Zahel, T., Haller, B. et al. Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival. World J Urol 34, 569–576 (2016). https://doi.org/10.1007/s00345-015-1654-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-015-1654-9